Shalby Limited has announced a leadership transition at its subsidiary level, with Deepak Anand resigning from his role as Chief Executive Officer of Shalby MedTech Limited. The company notes that Anand will step down with effect from the close of business hours on September 4, 2026, to relocate abroad for personal reasons. The board emphasises that there is no other material reason for the departure beyond these personal considerations, underscoring that the decision is entirely personal in nature.
In his resignation letter, Anand states his intent to ensure a smooth transition and to provide full cooperation during the notice period. While his departure marks a pivotal change for Shalby MedTech Limited, the move is framed as a personal decision rather than a commentary on the subsidiary’s performance or strategic direction. The group will now chart the path forward for the leadership of the wholly-owned subsidiary as it continues its operations and growth initiatives.
This development places renewed focus on leadership continuity within the Shalby ecosystem. As the company navigates the next phase of its growth, stakeholders will be watching how the subsidiary maintains momentum and executes its plans during the period of transition. The parent group is expected to outline the interim arrangements and any search or succession process in due course, as it remains committed to the ongoing success of Shalby MedTech Limited and the broader Shalby portfolio.